A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
Georgetown University
Assistance Publique - HĂ´pitaux de Paris
Azienda Ospedaliero-Universitaria di Parma
Azienda Ospedaliero-Universitaria di Parma
Baylor College of Medicine
Mayo Clinic
Cancer Research UK
University Health Network, Toronto
University of Heidelberg Medical Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Emory University
University of Michigan Rogel Cancer Center
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Baylor College of Medicine
Baylor College of Medicine
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Columbia University
University of Liverpool
University of Oxford
Case Comprehensive Cancer Center
Shenzhen University General Hospital
University Hospital Muenster
University of Haifa
University of Colorado, Boulder
Sunnybrook Health Sciences Centre
Hospices Civils de Lyon
Rabin Medical Center
Rutgers, The State University of New Jersey
Northwestern University
Baylor College of Medicine
University of California, San Francisco
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine